Physiology Foundations: Blood Glucose Regulation and Counterregulation

Why blood glucose needs tight regulation

Blood glucose is a continuously used fuel, especially for the brain and red blood cells. After eating, glucose enters the bloodstream quickly, but storage and use by tissues must be coordinated so glucose does not rise too high. During fasting, glucose input from the gut stops, but tissues still need a steady supply, so glucose must not fall too low. Glucose homeostasis is therefore a practical example of multi-hormone control: insulin and glucagon act in opposite directions, and their effects converge on two major processes: cellular glucose uptake and hepatic glucose output (liver release of glucose).

Key processes to track

• Cellular uptake: movement of glucose from blood into cells (especially skeletal muscle and adipose tissue).
• Hepatic glucose output: liver adds glucose to blood via glycogenolysis (breaking down glycogen) and gluconeogenesis (making new glucose).
• Storage vs release: liver can store glucose as glycogen after meals and release glucose during fasting.

(1) Timeline: post-meal to fasting (cause → hormone → tissue response)

A. Immediately after a carbohydrate-containing meal (0–30 minutes)

Cause: Glucose is absorbed from the intestine into the portal blood and then systemic circulation, raising plasma glucose.

Hormone changes:

• Insulin rises (pancreatic β-cells respond to increased glucose).
• Glucagon falls (pancreatic α-cells reduce secretion when glucose is high and insulin is high).

Tissue responses (effectors):

• Liver: decreases hepatic glucose output; increases glycogen synthesis (stores incoming glucose).
• Skeletal muscle: increases glucose uptake (insulin promotes GLUT4 translocation); increases glycogen synthesis.
• Adipose tissue: increases glucose uptake; increases triglyceride synthesis; decreases lipolysis.

Net effect on blood glucose: the rise is blunted and then reversed toward the normal range because glucose is being removed from blood and stored/used.

Continue in our app.

• Listen to the audio with the screen off.
• Earn a certificate upon completion.
• Over 5000 courses for you to explore!

Or continue reading below...

Download the app

B. Postprandial processing (30 minutes–3 hours)

Cause: Intestinal glucose delivery slows as the meal is processed; blood glucose begins to fall from its peak.

Hormone changes:

• Insulin gradually decreases as glucose returns toward baseline.
• Glucagon remains relatively suppressed compared with fasting, unless glucose falls rapidly.

Tissue responses:

• Liver: continues storing glucose early; later transitions toward less storage as insulin declines.
• Muscle/adipose: uptake remains elevated while insulin is elevated, then tapers.

Net effect: blood glucose returns toward baseline without overshooting into hypoglycemia in most healthy individuals.

C. Early fasting (3–12 hours after the meal)

Cause: No new glucose enters from the gut; tissues continue to consume glucose.

Hormone changes:

• Insulin falls (less stimulus from glucose).
• Glucagon rises (α-cells respond to lower glucose and lower insulin signaling).

Tissue responses:

• Liver: increases hepatic glucose output primarily via glycogenolysis; begins increasing gluconeogenesis.
• Muscle/adipose: reduced insulin means less GLUT4-mediated uptake; adipose increases lipolysis, providing fatty acids that many tissues can use, sparing glucose.

Net effect: liver glucose release offsets tissue use, stabilizing blood glucose.

D. Prolonged fasting (12–24+ hours)

Cause: Liver glycogen stores decline; ongoing need to maintain plasma glucose.

Hormone changes:

• Insulin remains low.
• Glucagon remains elevated.

Tissue responses:

• Liver: shifts toward greater reliance on gluconeogenesis (from lactate, glycerol, and amino acids); glycogenolysis contributes less as glycogen depletes.
• Peripheral tissues: increased use of fatty acids reduces glucose demand; this “glucose sparing” helps protect plasma glucose for glucose-dependent tissues.

Net effect: glucose is defended by increasing production rather than relying on dietary input.

E. Counterregulation: what happens if glucose drops too low?

Counterregulation refers to coordinated responses that prevent or correct hypoglycemia. In simplified terms for this chapter, focus on the first-line endocrine pattern:

• Insulin decreases (removes the “push” for uptake and storage).
• Glucagon increases (drives hepatic glucose output).

Cause-and-effect chain: falling glucose → reduced β-cell insulin secretion + increased α-cell glucagon secretion → liver increases glucose release → plasma glucose rises back toward normal.

(2) Component mapping: who senses, who decides, who acts?

Glucose regulation is a useful reminder that endocrine control can be distributed: multiple tissues both sense and respond, and the “controller” function is shared rather than centralized in a single organ.

Distributed endocrine control: a practical way to think about it

• Pancreas sets the hormonal “instructions” (insulin vs glucagon pattern).
• Liver is the main “buffer tank” that can either store glucose (after meals) or supply glucose (during fasting).
• Muscle and adipose are major “sinks” that remove glucose from blood when insulin is high.

Because different effectors respond on different time scales and with different capacities, the same hormone pattern can produce distinct outcomes depending on whether you are post-meal or fasting.

Two levers that determine blood glucose direction

When interpreting any scenario, ask two questions:

• Is glucose entering cells faster or slower? (mostly insulin-dependent in muscle/adipose)
• Is the liver adding glucose to blood faster or slower? (mostly glucagon-driven, insulin-inhibited)

If uptake increases and hepatic output decreases, glucose falls. If uptake decreases and hepatic output increases, glucose rises.

(3) Practice: interpret simplified glucose curves and predict hormone changes

In the exercises below, assume a healthy person unless stated otherwise. Your task is to predict the direction of change (rise/fall) for insulin and glucagon, and identify the dominant effector action (hepatic output vs cellular uptake).

How to approach each curve (step-by-step)

1. Identify the glucose trend: rising, falling, or stable.
2. Decide the immediate hormone pattern: rising glucose → insulin up, glucagon down; falling glucose → insulin down, glucagon up.
3. Predict effector changes: insulin up → uptake up and hepatic output down; glucagon up → hepatic output up.
4. Check for consistency: do the effector changes explain the observed glucose direction?

Curve A: classic post-meal rise then return to baseline

Time:   0   30   60   120  180 (min) Glucose: 90  140  125  100   90 (mg/dL)

• Hormones: insulin rises early (0–60 min) then falls; glucagon falls early then returns toward fasting level later.
• Dominant effector actions: increased cellular uptake (muscle/adipose) + decreased hepatic glucose output.
• Cause-and-effect sentence you should be able to say: “Meal absorption raises glucose, which increases insulin; insulin drives uptake and storage and suppresses liver output, bringing glucose back down.”

Curve B: gradual decline during fasting with stabilization

Time:   0    4    8    12   16 (hours) Glucose: 95   88   84   85   86 (mg/dL)

• Hormones: insulin decreases; glucagon increases.
• Dominant effector actions: increased hepatic glucose output (first glycogenolysis, then more gluconeogenesis) + reduced insulin-dependent uptake.
• Interpretation: the leveling off suggests counterregulatory hepatic output is matching tissue use.

Curve C: rapid drop below normal range (hypoglycemia pattern)

Time:   0   30   60   90 (min) Glucose: 90  75   60   55 (mg/dL)

• Hormones: insulin should fall quickly; glucagon should rise quickly.
• Dominant effector actions: liver increases glucose release; peripheral uptake pressure decreases due to low insulin.
• Checkpoint: if glucagon fails to rise (e.g., impaired α-cell response), hepatic output may not increase enough, and glucose can continue to fall.

Curve D: high glucose that stays elevated longer than expected

Time:   0   60   120  180 (min) Glucose: 95  170  165  150 (mg/dL)

• First-pass prediction in a healthy system: insulin should be high; glucagon should be low.
• Effector expectation: uptake should increase and hepatic output should decrease, so glucose should fall faster than shown.
• What the curve suggests (conceptual): either insulin is not rising enough, tissues are not responding to insulin effectively, hepatic output is not being suppressed adequately, or the meal glucose load is unusually large/continued.

Quick drill: fill in the blanks

Answer key (directions only):

• Large carbohydrate meal: insulin ↑, glucagon ↓, liver output ↓, cellular uptake ↑
• Overnight fast: insulin ↓, glucagon ↑, liver output ↑, cellular uptake ↓
• Sudden hypoglycemia: insulin ↓, glucagon ↑, liver output ↑, cellular uptake ↓